Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Verna

Showing results (111-120 of 222) with videos related to

Pageof 23
Sort By:
Transplantation|April 16, 2024
No Improvement in Intention-to-treat Survival and Increasing Liver Nonutilization Rate During the MELD EraRei Matsumoto, Elizabeth C Verna, Russell Rosenblatt, et al.
Pancreas|October 27, 2015
Progression of Incidental Intraductal Papillary Mucinous Neoplasms of the Pancreas in Liver Transplant RecipientsValerie Dorfman, Elizabeth C Verna, John M Poneros, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis CVarun Saxena, Jennifer C Lai, Jacqueline G O'Leary, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Predictors of candidate maturation among potential living donorsElizabeth C Verna, Kristel H Hunt, John F Renz, et al.
Hepatology (Baltimore, Md.)|May 31, 2020
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. CohortMeaghan M Phipps, Luis H Barraza, Elijah D LaSota, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2018
Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapyChristine Chan, Thomas Schiano, Eliana Agudelo, et al.
Transplantation|January 26, 2018
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in ChildrenEric M Przybyszewski, Elizabeth C Verna, Steven J Lobritto, et al.
Transplantation|September 12, 2014
Hepatitis C genotype influences post-liver transplant outcomesIsabel Campos-Varela, Jennifer C Lai, Elizabeth C Verna, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2012
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort studyJennifer C Lai, Jacqueline G O'Leary, James F Trotter, et al.
Archives of Pathology & Laboratory Medicine|April 18, 2020
COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver TransplantationStephen M Lagana, Simona De Michele, Michael J Lee, et al.
Pageof 23

Showing results (111-120 of 222) with videos related to

Sort By:
Pageof 23
Transplantation|April 16, 2024
No Improvement in Intention-to-treat Survival and Increasing Liver Nonutilization Rate During the MELD EraRei Matsumoto, Elizabeth C Verna, Russell Rosenblatt, et al.
Pancreas|October 27, 2015
Progression of Incidental Intraductal Papillary Mucinous Neoplasms of the Pancreas in Liver Transplant RecipientsValerie Dorfman, Elizabeth C Verna, John M Poneros, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis CVarun Saxena, Jennifer C Lai, Jacqueline G O'Leary, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Predictors of candidate maturation among potential living donorsElizabeth C Verna, Kristel H Hunt, John F Renz, et al.
Hepatology (Baltimore, Md.)|May 31, 2020
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. CohortMeaghan M Phipps, Luis H Barraza, Elijah D LaSota, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2018
Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapyChristine Chan, Thomas Schiano, Eliana Agudelo, et al.
Transplantation|January 26, 2018
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in ChildrenEric M Przybyszewski, Elizabeth C Verna, Steven J Lobritto, et al.
Transplantation|September 12, 2014
Hepatitis C genotype influences post-liver transplant outcomesIsabel Campos-Varela, Jennifer C Lai, Elizabeth C Verna, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2012
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort studyJennifer C Lai, Jacqueline G O'Leary, James F Trotter, et al.
Archives of Pathology & Laboratory Medicine|April 18, 2020
COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver TransplantationStephen M Lagana, Simona De Michele, Michael J Lee, et al.
Pageof 23